Evidence map›Paper›PMID 41955109›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

B cells enable autoreactive T cells to avoid suppression.

Matthew Funsten, Renee de Pooter, Vineeth Varanasi, Michael Burrows, Katharine Block, Andrey Kuznetsov, David Serreze, Haochu Huang, Alexander Chervonsky

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matthew Funsten *Department of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-4851-3468
Renee de Pooter *Department of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-3860-4155
Vineeth VaranasiDepartment of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-6542-5777
Michael BurrowsDepartment of Pathology, The University of Chicago, Chicago, IL 60637.
Katharine BlockDepartment of Pathology, The University of Chicago, Chicago, IL 60637.
Andrey KuznetsovDepartment of Pathology, The University of Chicago, Chicago, IL 60637.
David SerrezeThe Jackson Laboratory, Bar Harbor, ME 04609.ORCID 0000-0001-7614-5925
Haochu HuangDepartment of Pathology, The University of Chicago, Chicago, IL 60637.
Alexander ChervonskyDepartment of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0001-7547-871X

Funding

B-lymphocyte Targeting Therapies for Autoimmune DiabetesR01DK095735 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V · 2013 to 2025
$6.2M
Type 1 diabetes: the role of commensal microbiotaR01AI082418 · NIAID · UNIVERSITY OF CHICAGO · PI CHERVONSKY, ALEXANDER V · 2010 to 2020
$4.3M
HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) R01AI082418NIDDK NIH HHS R01 DK095735
6 · The paper itself

Abstract

Clinical trials and experimental observations have shown that B cells are essential for development of T cell-mediated organ-specific autoimmunity, although their exact contribution is not clear. As antigen presentation by B cells is focused on antigens cognate to their antigen receptors, we reasoned that B cells would facilitate activation of T effector cells (Teff) with the same antigen specificity but would poorly activate regulatory T cells (Treg) due to insufficient presence of antigen-specific Tregs among polyclonal/multispecific Tregs at the early stages of pathogenesis. At the same time, activation of Teff by autoantigens presented by dendritic cells (DC) would be sensitive to by-stander suppression by Tregs as DCs express a variety of antigenic peptides. We used Teff cells (KRN) and B cells (121) reactive to the same antigen - glucose-6-phosphate-isomerase (GPI) to show that KRN T cells activation was sensitive to polyclonal Tregs only when activated by DCs but not by B cells. However, as expected, GPI-specific Tregs were fully capable of suppressing Teff activation by B cells. Our findings shed light on the role of B cells in organ-specific autoimmunity and provide knowledge-based support for application of anti-B cell immunotherapies.

Indexed as

AutoimmunityB-LymphocytesT-Lymphocytes, RegulatoryAnimalsAutoantigensDendritic CellsLymphocyte ActivationMiceAutoantigensB cellsorgan-specific autoimmunityTregs

Identifiers

PMID41955109
PMCPMC13079398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.